Since 2010 our department has invested $60 million in these alternative technologies. The policy has been that after 2016 the market should pick up what the health community finds to be the best medical isotopes that fit its needs, so the goal of the program really is to bring these technologies up to commercialization so it can compete with other sources of medical isotopes going forward.
The advantage of these technologies—